Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksUnilever Regulatory News (ULVR)

Share Price Information for Unilever (ULVR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4,188.00
Bid: 4,185.00
Ask: 4,187.00
Change: 8.00 (0.19%)
Spread: 2.00 (0.048%)
Open: 4,164.00
High: 4,188.00
Low: 4,163.00
Prev. Close: 4,180.00
ULVR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Treatment of hyperinflationary countries

18 Sep 2019 14:00

RNS Number : 8366M
Unilever PLC
18 September 2019
 

Treatment of hyperinflationary countries in Underlying Sales Growth (USG)

 

 

Until Q2 2019 our definition of Underlying Sales Growth (USG) included the impact of volume and excluded the impact of price growth in Argentina and Venezuela, as consumer price inflation (CPI) rates had escalated to extreme levels.

 

After a full year of hyperinflationary conditions in Argentina, one of our larger markets, it became clear that these conditions would persist for some time. As a result, we announced with our second quarter results that we would review our definition of USG. Following the review, a new definition of USG for all countries with hyperinflationary economies will be adopted from Q3 2019 onwards, including a change to historical comparators. A normalised level of price growth will be included in USG, which will be capped at an annual rate that is equivalent to approximately 2% per month compounded. This cap is derived from one of the indicators of hyperinflation cited in IAS 29 and ensures that any price growth above this level will be excluded from USG.

 

This definition allows the full volume impact and limited price growth to be included in USG but avoids the distortion of hyperinflationary pricing beyond the capped level. We believe the new definition better reflects our normal pricing actions, distinct from those taken to respond to hyperinflationary conditions. This also brings our definition of USG more in-line with peer group companies.

 

The below tables show USG and UPG for the last four years restated on the new basis and a comparison with the previously reported numbers. There is no impact on turnover or any other line of the income statement.

 

 

 

SAFE HARBOUR

This announcement may contain forward-looking statements, including 'forward-looking statements' within the meaning of the United States Private Securities Litigation Reform Act of 1995. Words such as 'will', 'aim', 'expects', 'anticipates', 'intends', 'looks', 'believes', 'vision', or the negative of these terms and other similar expressions of future performance or results, and their negatives, are intended to identify such forward-looking statements. These forward-looking statements are based upon current expectations and assumptions regarding anticipated developments and other factors affecting the Unilever Group (the 'Group'). They are not historical facts, nor are they guarantees of future performance.

 

Because these forward-looking statements involve risks and uncertainties, there are important factors that could cause actual results to differ materially from those expressed or implied by these forward-looking statements. Among other risks and uncertainties, the material or principal factors which could cause actual results to differ materially are: Unilever's global brands not meeting consumer preferences; Unilever's ability to innovate and remain competitive; Unilever's investment choices in its portfolio management; inability to find sustainable solutions to support long-term growth including to plastic packaging; the effect of climate change on Unilever's business; significant changes or deterioration in customer relationships; the recruitment and retention of talented employees; disruptions in our supply chain and distribution; increases or volatility in the cost of raw materials and commodities; the production of safe and high quality products; secure and reliable IT infrastructure; execution of acquisitions, divestitures and business transformation projects; economic, social and political risks and natural disasters; financial risks; failure to meet high and ethical standards; and managing regulatory, tax and legal matters. These forward-looking statements speak only as of the date of this announcement. Except as required by any applicable law or regulation, the Group expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the Group's expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based. Further details of potential risks and uncertainties affecting the Group are described in the Group's filings with the London Stock Exchange, Euronext Amsterdam and the US Securities and Exchange Commission, including in the Annual Report on Form 20-F 2018 and the Unilever Annual Report and Accounts 2018.

 

 

 

UNDERLYING SALES GROWTH

UNDERLYING PRICE GROWTH

 

Beauty &

Personal

Care

Foods & Refresh-ment

Home

Care

Total

Unilever

Beauty &

Personal

Care

Foods & Refresh-ment

Home

Care

Total

Unilever

2016 Full Year

 

 

 

 

 

 

 

 

As previously reported (%)

4.2

2.7

4.9

3.7

2.6

2.6

3.6

2.8

Restated (%)

4.2

2.5

4.9

3.6

2.6

2.4

3.6

2.7

 

 

 

 

 

 

 

 

 

2017 Full Year

 

 

 

 

 

 

 

 

As previously reported (%)

2.9

2.7

4.4

3.1

1.5

3.0

2.3

2.3

Restated (%)

2.9

2.1

4.4

2.8

1.5

2.3

2.3

2.0

 

 

 

 

 

 

 

 

 

2018 H1

 

 

 

 

 

 

 

 

As previously reported (%)

2.7

1.8

3.5

2.5

(0.2)

0.6

0.3

0.2

Restated (%)

2.7

1.8

3.5

2.5

(0.2)

0.6

0.3

0.2

 

 

 

 

 

 

 

 

 

2018 H2

 

 

 

 

 

 

 

 

As previously reported (%)

3.5

2.3

4.9

3.4

1.5

1.0

3.6

1.7

Restated (%)

4.0

2.7

5.8

3.9

2.0

1.4

4.5

2.3

 

 

 

 

 

 

 

 

 

2018 Full Year

 

 

 

 

 

 

 

 

As previously reported (%)

3.1

2.0

4.2

2.9

0.6

0.7

1.9

0.9

Restated (%)

3.4

2.2

4.7

3.2

0.9

0.9

2.4

1.2

 

 

 

 

 

 

 

 

 

2019 H1

 

 

 

 

 

 

 

 

As previously reported (%)

3.3

1.3

7.4

3.3

1.6

1.4

4.5

2.1

Restated (%)

3.6

1.4

7.9

3.6

1.8

1.5

5.0

2.4

 

 

 

 

UNDERLYING SALES GROWTH

UNDERLYING PRICE GROWTH

 

The

Americas

LATAM

Emerging Markets

The

Americas

LATAM

Emerging Markets

2016 Full Year

 

 

 

 

 

 

As previously reported (%)

6.0

11.4

6.5

6.3

13.3

5.4

Restated (%)

5.7

10.8

6.4

6.0

12.7

5.3

 

 

 

 

 

 

 

2017 Full Year

 

 

 

 

 

 

As previously reported (%)

2.4

5.3

5.9

2.2

4.9

4.2

Restated (%)

1.6

3.5

5.4

1.4

3.1

3.7

 

 

 

 

 

 

 

2018 H1

 

 

 

 

 

 

As previously reported (%)

(0.8)

(2.6)

4.1

(0.3)

(0.4)

0.8

Restated (%)

(0.8)

(2.5)

4.1

(0.3)

(0.4)

0.8

 

 

 

 

 

 

 

2018 H2

 

 

 

 

 

 

As previously reported (%)

0.9

0.5

5.1

1.3

1.9

2.6

Restated (%)

2.5

4.1

6.0

3.0

5.5

3.6

 

 

 

 

 

 

 

2018 Full Year

 

 

 

 

 

 

As previously reported (%)

-

(1.0)

4.6

0.5

0.7

1.7

Restated (%)

0.8

0.8

5.0

1.3

2.6

2.1

 

 

 

 

 

 

 

2019 H1

 

 

 

 

 

 

As previously reported (%)

2.1

4.9

6.2

2.2

4.4

3.6

Restated (%)

3.0

7.0

6.7

3.1

6.5

4.1

 

 

 

 

 

 

 

UNDERLYING SALES GROWTH

UNDERLYING PRICE GROWTH

 

 

Beauty &

Personal

Care

Foods & Refresh-ment

Home

Care

Total

Unilever

Beauty &

Personal

Care

Foods & Refresh-ment

Home

Care

Total

Unilever

2016 Q1

As previously reported (%)

5.8

2.7

7.0

4.7

1.9

2.0

2.4

2.0

Restated (%)

5.8

2.6

7.0

4.6

1.9

1.9

2.4

2.0

2016 Q2

As previously reported (%)

5.6

3.5

6.0

4.7

2.2

2.7

4.5

2.8

Restated (%)

5.6

3.3

6.0

4.6

2.2

2.5

4.5

2.8

2016 Q3

As previously reported (%)

3.1

3.1

3.9

3.2

3.3

3.2

5.1

3.6

Restated (%)

3.1

2.9

3.9

3.1

3.3

2.9

5.1

3.5

2016 Q4

As previously reported (%)

2.5

1.4

3.0

2.2

3.0

2.4

2.3

2.6

Restated (%)

2.5

1.1

3.0

2.0

3.0

2.0

2.3

2.5

 

 

 

 

 

 

 

 

 

 

2017 Q1

As previously reported (%)

3.1

2.2

4.1

2.9

2.8

3.4

2.6

3.0

Restated (%)

3.1

1.6

4.1

2.7

2.8

2.8

2.6

2.7

2017 Q2

As previously reported (%)

2.2

3.9

2.5

3.0

2.5

3.7

2.4

3.0

Restated (%)

2.2

3.3

2.5

2.8

2.5

3.1

2.4

2.7

2017 Q3

As previously reported (%)

1.8

2.3

4.6

2.6

0.9

3.3

3.3

2.4

Restated (%)

1.8

0.9

4.6

1.9

0.9

1.9

3.3

1.8

2017 Q4

As previously reported (%)

4.4

2.3

6.5

4.0

-

1.3

1.1

0.7

Restated (%)

4.4

2.4

6.5

4.0

-

1.4

1.1

0.8

 

 

 

 

 

 

 

 

 

 

2018 Q1

As previously reported (%)

3.9

2.3

4.9

3.4

(0.2)

0.2

0.1

0.1

Restated (%)

3.9

2.3

4.9

3.4

(0.2)

0.2

0.1

0.1

2018 Q2

As previously reported (%)

1.6

1.3

2.2

1.6

(0.3)

0.8

0.6

0.3

Restated (%)

1.6

1.3

2.2

1.6

(0.3)

0.8

0.6

0.3

2018 Q3

As previously reported (%)

4.0

3.2

4.5

3.8

1.2

0.7

3.0

1.4

Restated (%)

4.5

3.6

5.5

4.4

1.7

1.1

3.9

1.9

2018 Q4

As previously reported (%)

3.0

1.3

5.3

2.9

1.7

1.4

4.1

2.1

Restated (%)

3.5

1.7

6.2

3.5

2.2

1.8

5.0

2.7

 

 

 

 

 

 

 

 

 

 

2019 Q1

As previously reported (%)

3.1

1.5

6.0

3.1

1.2

1.0

4.8

1.9

Restated (%)

3.4

1.7

6.4

3.4

1.4

1.2

5.2

2.2

2019 Q2

As previously reported (%)

3.5

1.0

8.9

3.5

1.9

1.6

4.3

2.3

Restated (%)

3.8

1.2

9.4

3.8

2.2

1.8

4.7

2.5

 

 

 

 

 

UNDERLYING SALES GROWTH

UNDERLYING PRICE GROWTH

 

 

The

Americas

LATAM

Emerging Markets

The

Americas

LATAM

Emerging Markets

2016 Q1

As previously reported (%)

8.5

17.9

8.3

7.3

15.1

4.4

Restated (%)

8.4

17.5

8.2

7.2

14.8

4.4

2016 Q2

As previously reported (%)

6.4

11.8

7.7

7.3

15.2

5.4

Restated (%)

6.1

11.3

7.6

7.0

14.6

5.3

2016 Q3

As previously reported (%)

5.8

9.7

5.6

8.0

15.5

6.6

Restated (%)

5.5

9.1

5.5

7.7

14.8

6.5

2016 Q4

As previously reported (%)

3.7

7.2

4.6

2.8

8.1

5.1

Restated (%)

3.2

6.3

4.3

2.4

7.1

4.9

 

 

 

 

 

 

 

 

2017 Q1

As previously reported (%)

1.2

3.5

6.1

3.4

7.1

5.3

Restated (%)

0.4

1.9

5.7

2.6

5.4

4.9

2017 Q2

As previously reported (%)

3.7

6.3

4.8

2.8

5.1

5.0

Restated (%)

2.8

4.4

4.3

1.9

3.2

4.5

2017 Q3

As previously reported (%)

1.4

6.6

6.3

2.9

7.0

4.4

Restated (%)

(0.5)

2.4

5.2

0.9

2.8

3.4

2017 Q4

As previously reported (%)

3.4

4.6

6.3

-

1.0

2.0

Restated (%)

3.6

5.0

6.4

0.2

1.4

2.1

 

 

 

 

 

 

 

 

2018 Q1

As previously reported (%)

2.5

2.2

5.1

(1.0)

(1.5)

0.8

Restated (%)

2.5

2.2

5.1

(1.0)

(1.4)

0.8

2018 Q2

As previously reported (%)

(3.8)

(6.9)

3.1

0.3

0.6

0.8

Restated (%)

(3.8)

(6.9)

3.1

0.3

0.7

0.8

2018 Q3

As previously reported (%)

1.7

1.5

5.6

1.5

1.4

2.1

Restated (%)

3.4

5.2

6.5

3.2

5.1

3.1

2018 Q4

As previously reported (%)

-

(0.4)

4.5

1.1

2.3

3.2

Restated (%)

1.7

3.1

5.4

2.8

5.9

4.1

 

 

 

 

 

 

 

 

2019 Q1

As previously reported (%)

0.4

0.4

5.0

2.1

4.6

3.2

Restated (%)

1.3

2.4

5.5

3.0

6.7

3.7

2019 Q2

As previously reported (%)

3.7

9.3

7.4

2.3

4.1

4.0

Restated (%)

4.6

11.6

7.9

3.3

6.4

4.5

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCCKFDBBBKDQCD
Date   Source Headline
1st May 20244:10 pmRNSResult of AGM
1st May 20243:17 pmRNSCommittee Composition
1st May 20249:06 amRNSTotal Voting Rights
25th Apr 20247:00 amRNSQ1 2024 Trading Statement
2nd Apr 20243:58 pmRNSTotal Voting Rights
28th Mar 20245:04 pmRNSDirector/PDMR Shareholding
27th Mar 202412:32 pmRNSDirector/PDMR Shareholding
26th Mar 20246:13 pmRNSDirector/PDMR Shareholding
26th Mar 202411:58 amRNSDirector/PDMR Shareholding
25th Mar 20243:10 pmRNSDirector/PDMR Shareholding
19th Mar 20247:00 amRNSUnilever to accelerate Growth Action Plan
18th Mar 20243:00 pmRNSNotice of AGM
14th Mar 20242:14 pmRNSAnnual Financial Report
13th Mar 20247:00 amRNSBlock Listing of Shares
11th Mar 20245:55 pmRNSDirector/PDMR Shareholding
1st Mar 20242:36 pmRNSTotal Voting Rights
19th Feb 20243:14 pmRNSDirector/PDMR Shareholding
8th Feb 20247:00 amRNSFinal Results
1st Feb 20245:04 pmRNSTotal Voting Rights
31st Jan 20243:00 pmRNSDirectorate Change
16th Jan 20245:10 pmRNSBlock listing Interim Review
2nd Jan 20242:54 pmRNSTotal Voting Rights
27th Dec 20237:00 amRNSDirector/PDMR Shareholding
15th Dec 20235:48 pmRNSDirector/PDMR Shareholding
12th Dec 20235:51 pmRNSDirector/PDMR Shareholding
11th Dec 20235:48 pmRNSDirector/PDMR Shareholding
11th Dec 20235:43 pmRNSDirector/PDMR Shareholding
4th Dec 20235:28 pmRNSTotal Voting Rights
23rd Nov 20233:51 pmRNSDirector/PDMR Shareholding
22nd Nov 20235:44 pmRNSDirector/PDMR Shareholding
10th Nov 20235:33 pmRNSDirector/PDMR Shareholding
8th Nov 20236:05 pmRNSDirector/PDMR Shareholding
1st Nov 20233:36 pmRNSTotal Voting Rights
30th Oct 20234:33 pmRNSStatement re Director Remuneration Report AGM Vote
26th Oct 20237:01 amRNSUnilever Announces New CFO
26th Oct 20237:00 amRNS3rd Quarter Results
18th Oct 20232:00 pmRNSCompletion of the 4th Tranche Share Buyback
17th Oct 20235:57 pmRNSTransaction in Own Shares
16th Oct 20236:01 pmRNSTransaction in Own Shares
13th Oct 20235:58 pmRNSTransaction in Own Shares
12th Oct 20235:50 pmRNSTransaction in Own Shares
12th Oct 20239:04 amRNSChanges to Membership of Board Committees
11th Oct 20236:06 pmRNSTransaction in Own Shares
11th Oct 20234:37 pmRNSDirector/PDMR Shareholding
10th Oct 20235:42 pmRNSTransaction in Own Shares
9th Oct 20236:05 pmRNSTransaction in Own Shares
6th Oct 20235:55 pmRNSTransaction in Own Shares
5th Oct 20235:46 pmRNSTransaction in Own Shares
4th Oct 20235:54 pmRNSTransaction in Own Shares
3rd Oct 20235:40 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.